Thyrotabs

28 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

1070.0%

Death Rate

Active Ingredients

Thyrotabs

Administration Routes

OralUnknown

Species Affected

Dog 28

Most Affected Breeds

Retriever - Labrador 5

Retriever - Golden 4

Greyhound 3

Terrier - Bull - American Pit 2

Spaniel - King Charles Cavalier 1

Great Pyrenees 1

Spaniel - Springer (unspecified) 1

Chow Chow 1

Pinscher - Miniature 1

Shepherd Dog - Australian 1

Most Reported Reactions

Lethargy (see also Central nervous system depression in Neurological) 5

Diarrhoea 4

Not eating 4

Behavioural disorder NOS 4

Vomiting 3

Vestibular disorder NOS 3

Limb weakness 3

Elevated alanine aminotransferase (ALT) 2

Lack of efficacy - NOS 2

Anorexia 2

Urinary incontinence 2

Injection site swelling 2

Outcome Breakdown

Ongoing

16 (57.1%)

Recovered/Normal

7 (25.0%)

Outcome Unknown

2 (7.1%)

Euthanized

2 (7.1%)

Died

1 (3.6%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.